SCHEMBL2493733

SCHEMBL2493733

[C]#CCC(C#C)C#CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1724145 0.80
SCHEMBL2892629 0.72
SCHEMBL2319318 0.67
SCHEMBL17555177 0.60
SCHEMBL9067340 0.58
SCHEMBL23152023 0.56
SCHEMBL5046288 0.55
SCHEMBL17479799 0.55
SCHEMBL27878 0.55
SCHEMBL5157604 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220409648-A1 NEUROLYTIC AGENTS AND METHODS OF USING AND IDENTIFYING SAME WASHINGTON UNIVERSITY 2022-12-29 US disclosed
EP-2654751-B1 PHOSPHORUS-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF PURDUE PHARMA LP (US) 2016-11-23 EP disclosed
EP-1618098-B1 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE PTC THERAPEUTICS INC (US) 2014-11-19 EP disclosed
US-8030310-B2 Therapeutic agents useful for treating pain PURDUE PHARMA, L.P. (US) 2011-10-04 US disclosed